Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace

Continue ReadingTeva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

3 FDA Decisions to Look Out for in February

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace

Continue Reading3 FDA Decisions to Look Out for in February

Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace

Continue ReadingNewcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi

Trump's CDC Director Resigns Over Pharma, Tobacco Investments

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Fitzgerald resigns four months after ex-HHS Secretary Price. Source: BioSpace

Continue ReadingTrump's CDC Director Resigns Over Pharma, Tobacco Investments

Booming Celltrion Falls After FDA Warning Letter

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Celltrion are down more than 5 percent after the company announced it received a warning letter from the FDA after the regulatory agency inspected a company drug manufacturing facility. Source:…

Continue ReadingBooming Celltrion Falls After FDA Warning Letter

Lilly Exploring Strategic Alternatives for Animal Health Biz

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Sluggish growth is the main driver for the decision.. Source: BioSpace

Continue ReadingLilly Exploring Strategic Alternatives for Animal Health Biz

Investors Elated as Vertex Picks Two Top CF Triple Combos for Phase III Trials

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy. Source: BioSpace

Continue ReadingInvestors Elated as Vertex Picks Two Top CF Triple Combos for Phase III Trials

Cambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

The company plans to initiate a Phase 2 clinical trial this year with AVR-RD-01 in Fabry disease. Source: BioSpace

Continue ReadingCambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic

Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace

Continue ReadingStada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016

Voyager Founder and CEO to Step Down, Hunt for New Leader Begins

  • Post author:Sam
  • Post published:January 31, 2018
  • Post category:BioPharma

Dr. Paul has been with the company for six years since its inception, initially as president of R&D, Source: BioSpace

Continue ReadingVoyager Founder and CEO to Step Down, Hunt for New Leader Begins
  • 1
  • 2
  • 3
  • 4
  • …
  • 34
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company